BlueRock Therapeutics Compagnie réclamée
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.
Lire la suite
the LTI program is very competitive
Qu’est-ce qui vous plaît le plus dans l’équipe de direction?
Expertise and experience. Inclusive style.
Qu’est-ce qui vous plaît le plus dans l’équipe de direction?
Humble leadership but some have more experience than others
Qu’est-ce qui est le plus positif à propos de la culture et de l’environnement de votre entreprise?
The community-oriented spirit and collaboration.
Qu’est-ce qui vous rend le plus heureux au travail?
The people and the oppportunity to make an impact.
Quelles sont les meilleures choses à propos de votre équipe?
We work really hard, but it's also a really fun and engaged group, which is really important to me!
Other Employee Reviews for BlueRock Therapeutics
×